Methylprednisolone Hikma Farmacêutica (Portugal)

Methylprednisolone sodium succinate, the active ingredient in Methylprednisolone Hikma Farmacêutica (Portugal), is a corticosteroid presented as an injectable solution for intramuscular and intravenous use. It is employed to manage severe allergic reactions, asthma exacerbations, rheumatoid arthritis flare‑ups, systemic lupus erythematosus, multiple sclerosis relapses, and adrenal insufficiency.

GNH USA supplies Methylprednisolone Hikma Farmacêutica (Portugal) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Methylprednisolone acts on inflammatory and immune pathways to control a range of acute and chronic conditions. - Severe allergic reactions: rapid reduction of airway swelling and systemic inflammation. - Asthma exacerbations: suppression of bronchial inflammation to improve breathing. - Rheumatoid arthritis flare‑ups: decrease joint swelling and pain. - Systemic lupus erythematosus: control of systemic immune activity. - Multiple sclerosis relapses: mitigation of neurologic inflammation. - Adrenal insufficiency: replacement of deficient glucocorticoid activity.

Methylprednisolone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Increased blood glucose levels. - Fluid retention and mild edema. - Mood changes such as irritability or euphoria. - Gastrointestinal discomfort or ulcer risk.

Serious or Rare Side Effects: - Severe infections due to immune suppression. - Osteonecrosis of the femoral head. - Adrenal crisis on abrupt discontinuation.

Use methylprednisolone only under medical supervision and consider patient‑specific risk factors. - Infection risk: monitor for signs of bacterial, viral, or fungal infection. - Diabetes management: check blood glucose regularly. - Bone health: assess risk of osteoporosis, especially with prolonged therapy. - Psychiatric effects: watch for mood swings, depression, or psychosis. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Methylprednisolone can alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Live vaccines: may cause uncontrolled infection. - Strong CYP3A4 inducers (e.g., rifampicin): reduce steroid effectiveness.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal bleeding. - Anticoagulants (warfarin): may enhance anticoagulant effect. - Diabetic agents: may require dose adjustment due to altered glucose control.